Everest Organics Ltd.

EVEREST ORG.

Market Cap
₹106 Cr.
P/E
550.05

Everest Organics Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
ROCE of the company has decreased even without significant capex
Depreciation Effect
Company is depreciating a greater percentage of assets. This is contributing to a reduction in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Unable to calculate due to limited data
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
Share price
Share price has increased over last 10 years but more due to rerating
ROE
Asset Turnover is responsible for ROE increase over last 10 years
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Debt
Company might have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a discount to 3 year historic valuations
ROE
Latest
-0.39%
3yr Average
10.5%
5yr Average
18.45%
Net Profit Margin
Latest
-0.1%
3yr Average
2.68%
5yr Average
3.87%
ROCE
Latest
5.29%
3yr Average
16.03%
5yr Average
25.78%
Debt to Equity
Latest
1.1
3yr Average
0.81
5yr Average
0.75
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Raw Material Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Manufacturing Capacity - Esomeprazole (MTPA)
      Source
    • Capacity Utilization - Esomeprazole (%)
      Source
    • Capacity Utilization - Benzimidazole (%)
      Source
    • Capacity Utilization - Omeprazole (%)
      Source
    • Realization - Pantaprazole Sodium (Rs/Tonne)
      Source
    • Realization - Ammonium Sulphate (Rs/Tonne)
      Source
    • Realization - Esomeprazole Magnesium (Rs/Tonne)
      Source
    • Realization - Chloro Compound (Rs/Tonne)
      Source
    • Manufacturing Capacity - Pantaprazole (MTPA)
      Source
    • Realization - Omeprazole Powder (Rs/Tonne)
      Source
    • Manufacturing Capacity - Benzimidazole (MTPA)
      Source
    • Capacity Utilization - Chloro Compound (%)
      Source
    • Realization - Benzimidazole (Rs/Tonne)
      Source
    • Realization - Op. Sulphide (Rs/Tonne)
      Source
    • Capacity Utilization - Pantaprazole (%)
      Source
    • Manufacturing Capacity - Chloro Compound (MTPA)
      Source
    • Realization - Tetralone (Rs/Tonne)
      Source
    • Manufacturing Capacity - Omeprazole (MTPA)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Everest Organics Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline